From confusion to a
clear path toward treatment.
Our mission is simple: help patients move from confusion to a clear path toward treatment — through coverage, assistance, or both.
No false promises. No vague coverage claims. No dead ends.
MedicineCostHelp connects expensive medicines to the insurance policies, manufacturer programs, independent foundations and other official resources that may matter. We summarize enough to help people know where to look next, then link to the source that controls.
We do not diagnose, prescribe, make coverage determinations, guarantee reimbursement, guarantee grant eligibility, or tell patients to switch medicines. The insurer, treatment site, prescriber, manufacturer program or independent foundation makes those decisions.
MedicineCostHelp
Independent patient medication-access resource
Built from over 20 years of oncology and infusion pharmacy experience.
MedicineCostHelp is provided by MedicineCostHelp LLC, a Washington limited liability company. The public-facing resource remains branded simply as MedicineCostHelp.
Official sources first. Automation for detection. Humans for meaning.
We prefer insurer, Medicare/CMS, Medicaid, manufacturer and other first-party sources.
We route to official manufacturer support and independent charitable-assistance organizations, with live-status directories where available.
Automated systems watch for source changes, broken links, new codes and funding-page changes. Alerts trigger review; they do not silently rewrite public guidance.
When something can change quickly, we tell users to verify the current source rather than present an old status as fact.
Patients and care teams can report an outdated source or broken link without sending patient health information. Reports enter the same human-review philosophy as automated alerts.
See how the answer is built.
MedicineCostHelp treats sourcing, corrections, independence and accessibility as product features. These pages document the rules behind the public guidance.
Maintenance is part of the product.
FDA novel drugs, biosimilars, oncology approvals and CBER biologics are reviewed for medicines that belong in the library.
Payer-source changes are flagged for human review before coverage guidance changes.
CMS HCPCS quarterly files and coding decisions are monitored because new products can move from unclassified billing to permanent codes.
Manufacturer and independent funding resources are checked for source movement, availability changes and broken links.
Useful information only matters if it reaches the patient.
MedicineCostHelp provides a free public sharing toolkit for care teams and advocacy organizations: a printable QR handout, copyable patient introduction, medicine-guide links and a privacy-first Coverage Action Plan. Organizations can share the public resource without sending patient data to MedicineCostHelp.
Open the patient handoff toolkit →What MedicineCostHelp is
A U.S.-focused educational navigation resource designed to help patients, caregivers and healthcare teams find the right official place to verify coverage and financial-assistance options for expensive therapies.
See what we cover → Explore grants and foundations → For clinics & care teams → Report a correction →